Galantamine Tablet, Film Coated
Product Images NDC 57237-051

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Galantamine (NDC 57237-051). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure 1: Time-course Of The Change From Baseline In Adas-cog Score For Patients Completing 21 Weeks (5 Months) Of (Galantamine Fig1)

Figure 1: Time-course Of The Change From Baseline In Adas-cog Score For Patients Completing 21 Weeks (5 Months) Of (Galantamine Fig1)
FDA Label Image

Galantamine Fig10

Galantamine Fig10
FDA Label Image

Galantamine Fig11

Galantamine Fig11
FDA Label Image

Figure 12 (Galantamine Fig12)

Figure 12 (Galantamine Fig12)
FDA Label Image

Package Label-principal Display Panel (4 mg (60 Tablets Bottle))

Package Label-principal Display Panel (4 mg (60 Tablets Bottle))
This is a description for Galantamine Tablets, USP made in India consisting of 60 tablets. Each film-coated tablet has Galantaming hydrobromida USP and is equivalent to 4 mg galantamine bass. The recommended usual dosage is provided in the accompanying product literature. The tablets should be stored between 20° to 25°C (68°F to 77°F) with excursions permitted between 15°C to 30°C (59°F to 86°F). It is important to keep the tablets out of reach of children. The revision date for this product is 01/2018.*
FDA Label Image

Package Label-principal Display Panel (8 mg (60 Tablets Bottle))

Package Label-principal Display Panel (8 mg (60 Tablets Bottle))
FDA Label Image

Package Label-principal Display Panel (12 mg (60 Tablets Bottle))

Package Label-principal Display Panel (12 mg (60 Tablets Bottle))
The text describes a medication called "Rising Nocs7257-051-50 Galantamine Tablets, USP". Each film-coated tablet contains 12 mg of galantamine hydrobromide USP. The product literature provides instructions to store the medicine between 20° to 25°C and keep it out of reach of children. The medication is distributed by Fising Health, LLC and was made in India. The description also includes a revision date of 01/2018 and a code of TS/DRUGS/10/1993. The text mentions an "over printing zone," but it is not clear what that refers to.*
FDA Label Image

Galantamine Fig2

Galantamine Fig2
FDA Label Image

Galantamine Fig3

Galantamine Fig3
FDA Label Image

Galantamine Fig4

Galantamine Fig4
FDA Label Image

Figure 5 (Galantamine Fig5)

Figure 5 (Galantamine Fig5)
FDA Label Image

Galantamine Fig6

Galantamine Fig6
FDA Label Image

Galantamine Fig7

Galantamine Fig7
FDA Label Image

Figure 8 (Galantamine Fig8)

Figure 8 (Galantamine Fig8)
The text seems to be a graph or chart and it shows the Cumulative Percentage of Patients with no change in ADAS-cog score from Baseline. The X-axis has values ranging from -5 to 15 with increments of 5, indicating the ADAS-cog Change From Baseline. The Y-axis shows the percentage of patients. The chart has two lines, one representing the placebo group and the other showing 24 my/day or 32 my/day groups. No further information is available from the given text.*
FDA Label Image

Galantamine Fig9

Galantamine Fig9
FDA Label Image

Structure (Galantamine Str)

Structure (Galantamine Str)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.